SEC Panel: Adjusted Tick Size 'Mite' Aid Newly Public Firms
By Randy Osborne
Friday, February 1, 2013
As small biotech firms and others struggle with ways to go public and stay afloat after they do, the Securities and Exchange Commission's (SEC) Advisory Committee on Small and Emerging Companies met for the third time to sort through possible relief routes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.